Works matching IS 2162-4011 AND VI 2 AND IP 10 AND DT 2013

Results: 32

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26286-1, doi. 10.4161/onci.26286

By:

John, Liza B.;
Kershaw, Michael H.;
Darcy, Phillip K.

Publication type:

Article

Clarifying the pharmacodynamics of tecemotide (L-BLP25)-based combination therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26285-1, doi. 10.4161/onci.26285

By:

Chiao-Jung Kao;
Wurz, Gregory T.;
Schröder, Andreas;
Wolf, Michael;
DeGregorio, Michael W.

Publication type:

Article

Potentiating antitumor immunity with αGC-loaded exosomes.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26261-1, doi. 10.4161/onci.26261

By:

Gehrmann, Ulf;
Hiltbrunner, Stefanie;
Näslund, Tanja I.;
Gabrielsson, Susanne

Publication type:

Article

Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26260-1, doi. 10.4161/onci.26260

By:

Garg, Abhishek D.;
Dudek, Aleksandra M.;
Agostinis, Patrizia

Publication type:

Article

FOXP3-specific immunity.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26247-1, doi. 10.4161/onci.26247

By:

Andersen, Mads Hald

Publication type:

Article

Tumor-infiltrating follicular helper T cells The new kids on the block.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26066-1, doi. 10.4161/onci.26066

By:

Gu-Trantien, Chunyan;
Willard-Gallo, Karen

Publication type:

Article

Tumor-targeting vaccination instructs graft-vs.-tumor immune responses.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25996-1, doi. 10.4161/onci.25996

By:

Manzo, Teresa;
Michelini, Rodrigo Hess;
Sturmheit, Tabea;
Basso, Veronica;
Bellone, Matteo;
Mondino, Anna

Publication type:

Article

Is there a future for adoptive cell transfer in melanoma patients?

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26098-1, doi. 10.4161/onci.26098

By:

Besser, Michal J.

Publication type:

Article

Chemokine-enhanced DNA vaccination in cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26092-1, doi. 10.4161/onci.26092

By:

Igoucheva, Olga;
Jonas, Rebecca;
Alexeev, Vitali

Publication type:

Article

Extending the chimeric receptor-based T-cell targeting strategy to solid tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26091-1, doi. 10.4161/onci.26091

By:

Rossig, Claudia

Publication type:

Article

The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25997-1, doi. 10.4161/onci.25997

By:

Demaria, Sandra;
Vanpouille-Box, Claire;
Formenti, Silvia C.;
Adams, Sylvia

Publication type:

Article

Adoptive immunotherapy New assay for the identification of T cells with optimal avidity.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26199-1, doi. 10.4161/onci.26199

By:

Weissbrich, Bianca;
Nauerth, Magdalena;
Busch, Dirk H.

Publication type:

Article

Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25990-1, doi. 10.4161/onci.25990

By:

Hirt, Christian;
Eppenberger-Castori, Serenella;
Sconocchia, Giuseppe;
Iezzi, Giandomenica;
Tornillo, Luigi;
Terracciano, Luigi;
Spagnoli, Giulio C.;
Droeser, Raoul A.

Publication type:

Article

Combining cellular and gene therapy approaches for treatment of intracranial tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25989-1, doi. 10.4161/onci.25989

By:

Hickey, Michelle J.;
Kasahara, Noriyuki;
Mueller, Barbara M.;
Kruse, Carol A.

Publication type:

Article

Cell-in-cell A virgin land of cell biology.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25988-1, doi. 10.4161/onci.25988

By:

Ying Wang;
Xiao-ning Wang

Publication type:

Article

MAGE-A3-specific anticancer immunotherapy in the clinical practice.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25995-1, doi. 10.4161/onci.25995

By:

Brichard, Vincent G.;
Godechal, Quentin

Publication type:

Article

Intratumoral mast cells promote the growth of pancreatic cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25964-1, doi. 10.4161/onci.25964

By:

Ying Ma;
Ullrich, Stephen E.

Publication type:

Article

A new role for NFkB in immunosurveillance and its implications for cancer immunotherapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25963-1, doi. 10.4161/onci.25963

By:

Beg, Amer A.;
Khan, Tahira;
Antonia, Scott J.

Publication type:

Article

Replenish the source within Rescuing tumor-infiltrating lymphocytes by double checkpoint blockade.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25912-1, doi. 10.4161/onci.25912

By:

Duraiswamy, Jaikumar;
Freeman, Gordon;
Coukos, George

Publication type:

Article

A new mouse model of inflammation and gastric cancer.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25911-1, doi. 10.4161/onci.25911

By:

Nguyen, Thanh-Long M.;
DiPaolo, Richard J.

Publication type:

Article

Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination.

Published in:

2013

By:

Litterman, Adam J.;
Dudek, Arkadiusz Z.;
Largaespada, David A.

Publication type:

Opinion

Adverse events to monoclonal antibodies used for cancer therapy Focus on hypersensitivity responses.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26333-1, doi. 10.4161/onci.26333

By:

Baldo, Brian A.

Publication type:

Article

Assessing T-cell responses in anticancer immunotherapy Dendritic cells or myeloid-derived suppressor cells?

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26148-1, doi. 10.4161/onci.26148

By:

Escors, David;
Liechtenstein, Therese;
Perez-Janices, Noemi;
Schwarze, Julia;
Dufait, Ines;
Goyvaerts, Cleo;
Lanna, Alessio;
Arce, Frederick;
Blanco-Luquin, Idoia;
Kochan, Grazyna;
Guerrero-Setas, David;
Breckpot, Karine

Publication type:

Article

Trial Watch Dendritic cell-based interventions for cancer therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e25771-1, doi. 10.4161/onci.25771

By:

Vacchelli, Erika;
Vitale, Ilio;
Eggermont, Alexander;
Fridman, Wolf Hervé;
Fučíková, Jitka;
Cremer, Isabelle;
Galon, Jérôme;
Tartour, Eric;
Zitvogel, Laurence;
Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

New prospects on the NKG2D/NKG2DL system for oncology.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26097-1, doi. 10.4161/onci.26097

By:

Ullrich, Evelyn;
Koch, Joachim;
Cerwenka, Adelheid;
Steinle, Alexander

Publication type:

Article

HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26616-1, doi. 10.4161/onci.26616

By:

Gowda, Madhu;
Payne, Kyle K.;
Godder, Kamar;
Manjili, Masoud H.

Publication type:

Article

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26615-1, doi. 10.4161/onci.26615

By:

Cooper, Zachary A.;
Frederick, Dennie T.;
Juneja, Vikram R.;
Sullivan, Ryan J.;
Lawrence, Donald P.;
Piris, Adriano;
Sharpe, Arlene H.;
Fisher, David E.;
Flaherty, Keith T.;
Wargo, Jennifer A.

Publication type:

Article

Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26381-1, doi. 10.4161/onci.26381

By:

Hasumi, Kenichiro;
Aoki, Yukimasa;
Watanabe, Ryuko;
Mann, Dean L.

Publication type:

Article

Effects of conventional therapeutic interventions on the number and function of regulatory T cells.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e27025-1, doi. 10.4161/onci.27025

By:

Roselli, Mario;
Cereda, Vittore;
di Bari, Maria Giovanna;
Formica, Vincenzo;
Spila, Antonella;
Jochems, Caroline;
Farsaci, Benedetto;
Donahue, Renee;
Gulley, James L.;
Schlom, Jeffrey;
Guadagni, Fiorella

Publication type:

Article

Immunogenic cell death in radiation therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e27025-1, doi. 10.4161/onci.26536

By:

Galluzzi, Lorenzo;
Kepp, Oliver;
Kroemer, Guido

Publication type:

Article

Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibodydependent cellular cytotoxicity.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26527-1, doi. 10.4161/onci.26527

By:

Boissel, Laurent;
Betancur-Boissel, Monica;
Weiquan Lu;
Krause, Daniela S.;
Van Etten, Richard A.;
Wels, Winfried S.;
Klingemann, Hans

Publication type:

Article

APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells.

Published in:

OncoImmunology, 2013, v. 2, n. 10, p. e26293-1, doi. 10.4161/onci.26293

By:

Peters, Haley L.;
Ying Yan;
Solheim, Joyce C.

Publication type:

Article